اکثر مکاتبات کومش از طریق ایمیل سایت می باشد. لطفا Spam ایمیل خود را نیز چک نمایید.
   [Home ] [Archive]   [ فارسی ]  
:: ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
Subscription::
Contact us::
Site Facilities::
Webmail::
Editorial Board::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 25, Issue 5 (Sep and Oct 2023 2023) ::
Koomesh 2023, 25(5): 778-778 Back to browse issues page
Comparative Study of Disturbance in the Peripheral Thyroid Hormone Homeostasis in the Hemodialysis Patients with End Stage Renal Disease (ESRD) in Diabetic and Non-diabetic Subjects
Abolfazl Fateh , Enayat Anvari
Abstract:   (261 Views)
Introduction: Chronic kidney disease (CKD) is a leading cause of death and morbidity in developed countries. Although, recent studies have shown that the prevalence of thyroid disorders is higher in the individuals with CKD, however, the underlying mechanisms is not clear. Evaluation the blood levels of thyroid hormones in diabetic (diabetes type 2) and non-diabetic patients with end stage renal disease (ESRD) on hemodialysis was the objective of the current study.
Methods and Materials: The serum thyroid hormone levels including thyroid stimulating hormone (TSH), 3, 5, 3', 5'-tetraiodothyronine (T4/thyroxine) and 3, 3', 5-triiodothyronine (T3) were measured using the enzyme-linked immunosorbent assay (ELISA) method. Furthermore, kidney function tests (urea and creatinine), uric acid, serum lipid profile (total cholesterol, low density lipoprotein cholesterol/LDLc, high density lipoprotein cholesterol/HDLc and triglyceride) and fasting blood glucose/FBS have been measured using spectrophotometry-based methods.
Results: Although the differences in the levels of thyroid function hormones, including TSH, T4 and T3, in hemodialysis-diabetic subjects (HDS) were not statistically significant as compared to hemodialysis-non-diabetics (HNDS), however, the ratio of triiodothyronine (T3) to thyroxine (T4) i.e. T3/T4 ratio was significantly different in both genders (p-value<0.05). For women, this ratio (mean±standard error of the mean) was 0.220±0.026 and 0.554±0.12 in HDS as compared to the HNDS, respectively. For men, this ratio was 0.205±0.01 and 0.295±0.05 in HDS in comparison with HNDS, respectively.
Conclusion: There is a difference in the T3/T4 ratio hemostasis in HDS in comparison with HNDS and it is not related to the hypothalamic-pituitary-thyroid axis and maybe peripheral factors including enzymes such as iodothyronine deiodinase type 1 and type 2, which are involved in the regulation of serum thyroid hormone levels, are responsible for the observed differences.
 
Keywords: Chronic kidney disease, Triiodothyronine, Thyroxine, TSH, T3/T4 ratio, Diabetes
Full-Text [PDF 385 kb]   (29 Downloads)    
Type of Study: Research | Subject: General
Received: 2024/02/25 | Accepted: 2023/08/10 | Published: 2023/08/10
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Fateh A, Anvari E. Comparative Study of Disturbance in the Peripheral Thyroid Hormone Homeostasis in the Hemodialysis Patients with End Stage Renal Disease (ESRD) in Diabetic and Non-diabetic Subjects. Koomesh 2023; 25 (5) :778-778
URL: http://koomeshjournal.semums.ac.ir/article-1-8999-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 25, Issue 5 (Sep and Oct 2023 2023) Back to browse issues page
کومش Koomesh
Persian site map - English site map - Created in 0.06 seconds with 38 queries by YEKTAWEB 4645